Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer
Authors
Keywords
-
Journal
Frontiers in Medicine
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-09-03
DOI
10.3389/fmed.2020.00495
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Altered exocrine function can drive adipose wasting in early pancreatic cancer
- (2018) Laura V. Danai et al. NATURE
- Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe
- (2018) Muhammad Ahsan Javed et al. PANCREATOLOGY
- 3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer
- (2017) Manfred P. Lutz et al. EUROPEAN JOURNAL OF CANCER
- Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study
- (2017) Maurizio Muscaritoli et al. Oncotarget
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Chemotherapy dose intensity predicted by baseline nutrition assessment in gastrointestinal malignancies: A multicentre analysis
- (2016) Kelsey A. Klute et al. EUROPEAN JOURNAL OF CANCER
- Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: A systematic review
- (2015) I. Ozola Zalite et al. PANCREATOLOGY
- Neoadjuvant FOLFIRINOX Application in Borderline Resectable Pancreatic Adenocarcinoma
- (2014) Alessandro Paniccia et al. MEDICINE
- Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer
- (2013) Brian A. Boone et al. JOURNAL OF SURGICAL ONCOLOGY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Role of the FOLFIRINOX Regimen for Advanced Pancreatic Cancer
- (2013) Thierry Conroy et al. Current Oncology Reports
- Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer
- (2012) Stefano Partelli et al. DIGESTIVE AND LIVER DISEASE
- Understanding the mechanisms and treatment options in cancer cachexia
- (2012) Kenneth Fearon et al. Nature Reviews Clinical Oncology
- Nutritional Status Affects Treatment Tolerability and Survival in Metastatic Colorectal Cancer Patients: Results of an AGEO Prospective Multicenter Study
- (2012) Maximilien Barret et al. ONCOLOGY
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now